{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T01:07:47Z","timestamp":1790557667876,"version":"4.1.0"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T00:00:00Z","timestamp":1767052800000},"content-version":"am","delay-in-days":332,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100008460","name":"National Center for Complementary and Integrative Health","doi-asserted-by":"publisher","award":["AT012494"],"award-info":[{"award-number":["AT012494"]}],"id":[{"id":"10.13039\/100008460","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["UL1 TR001414"],"award-info":[{"award-number":["UL1 TR001414"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["NS072234"],"award-info":[{"award-number":["NS072234"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["CA263806"],"award-info":[{"award-number":["CA263806"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R01"],"award-info":[{"award-number":["R01"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017476","name":"Urban Child Institute","doi-asserted-by":"publisher","award":["NS082174"],"award-info":[{"award-number":["NS082174"]}],"id":[{"id":"10.13039\/100017476","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017476","name":"Urban Child Institute","doi-asserted-by":"publisher","award":["P30CA062203"],"award-info":[{"award-number":["P30CA062203"]}],"id":[{"id":"10.13039\/100017476","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017476","name":"Urban Child Institute","doi-asserted-by":"publisher","award":["5 TL1 TR 1415-8"],"award-info":[{"award-number":["5 TL1 TR 1415-8"]}],"id":[{"id":"10.13039\/100017476","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002112","name":"A.P. Giannini Foundation","doi-asserted-by":"publisher","award":["AT012494"],"award-info":[{"award-number":["AT012494"]}],"id":[{"id":"10.13039\/100002112","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.canlet.2024.217405","type":"journal-article","created":{"date-parts":[[2024,12,19]],"date-time":"2024-12-19T03:09:14Z","timestamp":1734577754000},"page":"217405","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["N-acetylcysteine prevents cisplatin-induced cognitive impairments in an ovarian cancer rat model"],"prefix":"10.1016","volume":"611","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1071-386X","authenticated-orcid":false,"given":"Naomi","family":"Lomeli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana C.","family":"Pearre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Lepe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donovan A.","family":"Argueta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mya A.","family":"Arellano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joni L.","family":"Ricks-Oddie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kalpna","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9680-9060","authenticated-orcid":false,"given":"Daniela A.","family":"Bota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.canlet.2024.217405_bib1","first-page":"19","article-title":"Chemotherapy-related cognitive dysfunction and effects on quality of life in gynecologic cancer patients","volume":"3","author":"Pearre","year":"2018","journal-title":"Expert Rev Qual Life Cancer Care"},{"key":"10.1016\/j.canlet.2024.217405_bib2","unstructured":"(NIH\/NCI) NCI. Cancer Statistics https:\/\/www.cancer.gov\/about-cancer\/understanding\/statistics#:\u223c:text=As%20of%20January%202022%2C%20there,on%202017%E2%80%932019%20data. Accessed."},{"key":"10.1016\/j.canlet.2024.217405_bib3","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.freeradbiomed.2016.11.046","article-title":"Cisplatin-induced mitochondrial dysfunction is associated with impaired cognitive function in rats","volume":"102","author":"Lomeli","year":"2017","journal-title":"Free Radic. Biol. Med."},{"issue":"1","key":"10.1016\/j.canlet.2024.217405_bib4","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/s000180300001","article-title":"Molecular mechanisms of N-acetylcysteine actions","volume":"60","author":"Zafarullah","year":"2003","journal-title":"Cellular and Molecular Life Sciences CMLS"},{"issue":"2","key":"10.1016\/j.canlet.2024.217405_bib5","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s00280-007-0597-2","article-title":"Effect of N-acetylcysteine route of administration on chemoprotection against cisplatin-induced toxicity in rat models","volume":"62","author":"Dickey","year":"2008","journal-title":"Cancer Chemother. Pharmacol."},{"issue":"1\u20132","key":"10.1016\/j.canlet.2024.217405_bib6","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.heares.2004.02.007","article-title":"Protection against cisplatin-induced ototoxicity by N-acetylcysteine in a rat model","volume":"193","author":"Thomas Dickey","year":"2004","journal-title":"Hear. Res."},{"key":"10.1016\/j.canlet.2024.217405_bib7","article-title":"Cisplatin toxicity in dorsal root ganglion neurons is relieved by meclizine via diminution of mitochondrial compromise and improved clearance of DNA damage","author":"Gorgun","year":"2016","journal-title":"Mol. Neurobiol."},{"issue":"5","key":"10.1016\/j.canlet.2024.217405_bib8","first-page":"319","article-title":"Use of antioxidants during chemotherapy and radiotherapy should be avoided","volume":"55","author":"D'Andrea","year":"2005","journal-title":"CA A Cancer J. Clin."},{"issue":"19","key":"10.1016\/j.canlet.2024.217405_bib9","article-title":"N-acetylcysteine chemoprotection without decreased cisplatin antitumor efficacy in pediatric tumor models","volume":"74","author":"Muldoon","year":"2014","journal-title":"Cancer Res."},{"issue":"6","key":"10.1016\/j.canlet.2024.217405_bib10","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.suponc.2010.09.028","article-title":"Pilot study of the prospective identification of changes in cognitive function during chemotherapy treatment for advanced ovarian cancer","volume":"8","author":"Hess","year":"2010","journal-title":"J. Support Oncol."},{"key":"10.1016\/j.canlet.2024.217405_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.expneurol.2024.114717","article-title":"Cisplatin induces BDNF downregulation in middle-aged female rat model while BDNF enhancement attenuates cisplatin neurotoxicity","volume":"375","author":"Lomeli","year":"2024","journal-title":"Exp. Neurol."},{"issue":"4","key":"10.1016\/j.canlet.2024.217405_bib12","first-page":"891","article-title":"Enhanced c-erbB-2\/neu expression in human ovarian cancer cells correlates with more severe malignancy that can be suppressed by E1A","volume":"53","author":"Yu","year":"1993","journal-title":"Cancer Res."},{"issue":"3","key":"10.1016\/j.canlet.2024.217405_bib13","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1007\/BF00300234","article-title":"Determination of subcutaneous tumor size in athymic (nude) mice","volume":"24","author":"Tomayko","year":"1989","journal-title":"Cancer Chemother. Pharmacol."},{"issue":"2","key":"10.1016\/j.canlet.2024.217405_bib14","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1007\/s11682-021-00525-5","article-title":"Altered regional homogeneity in patients with ovarian cancer treated with chemotherapy: a resting state fMRI study","volume":"16","author":"Vachha","year":"2022","journal-title":"Brain Imaging Behav"},{"key":"10.1016\/j.canlet.2024.217405_bib15","article-title":"Altered resting-state hippocampal functional networks associated with chemotherapy-induced prospective memory impairment in breast cancer survivors","volume":"7","author":"Cheng","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.canlet.2024.217405_bib16","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.redox.2018.08.003","article-title":"Hippocampal neurons require a large pool of glutathione to sustain dendrite integrity and cognitive function","volume":"19","author":"Fernandez-Fernandez","year":"2018","journal-title":"Redox Biol."},{"issue":"3","key":"10.1016\/j.canlet.2024.217405_bib17","doi-asserted-by":"crossref","first-page":"218","DOI":"10.5811\/westjem.2012.4.6885","article-title":"Oral and intravenous acetylcysteine for treatment of acetaminophen toxicity: a systematic review and meta-analysis","volume":"14","author":"Green","year":"2013","journal-title":"West. J. Emerg. Med."},{"issue":"27","key":"10.1016\/j.canlet.2024.217405_bib18","doi-asserted-by":"crossref","first-page":"20116","DOI":"10.1016\/S0021-9258(20)80702-9","article-title":"Glutathione-associated cis-diamminedichloroplatinum(II) metabolism and ATP-dependent efflux from leukemia cells. Molecular characterization of glutathione-platinum complex and its biological significance","volume":"268","author":"Ishikawa","year":"1993","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.canlet.2024.217405_bib19","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.chembiol.2018.01.011","article-title":"N-acetyl cysteine functions as a fast-acting antioxidant by triggering intracellular H2S and sulfane sulfur production","volume":"25","author":"Ezerina","year":"2018","journal-title":"Cell Chem. Biol."},{"key":"10.1016\/j.canlet.2024.217405_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2021.107916","article-title":"The mechanism of action of N-acetylcysteine (NAC): the emerging role of H(2)S and sulfane sulfur species","volume":"228","author":"Pedre","year":"2021","journal-title":"Pharmacol. Ther."},{"issue":"8","key":"10.1016\/j.canlet.2024.217405_bib21","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.1002\/jps.24482","article-title":"Intravenous administration of stable-labeled N-acetylcysteine demonstrates an indirect mechanism for boosting glutathione and improving redox status","volume":"104","author":"Zhou","year":"2015","journal-title":"J. Pharmaceut. Sci."},{"issue":"12","key":"10.1016\/j.canlet.2024.217405_bib22","doi-asserted-by":"crossref","first-page":"4653","DOI":"10.1002\/jps.23325","article-title":"Interaction of N-acetylcysteine and cysteine in human plasma","volume":"101","author":"Radtke","year":"2012","journal-title":"J. Pharmaceut. Sci."},{"issue":"10","key":"10.1016\/j.canlet.2024.217405_bib23","article-title":"N-Acetylcysteine clinical applications","volume":"16","author":"Yahia","year":"2024","journal-title":"Cureus"},{"issue":"8","key":"10.1016\/j.canlet.2024.217405_bib24","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1212\/WNL.57.8.1515","article-title":"Controlled trial of N-acetylcysteine for patients with probable Alzheimer's disease","volume":"57","author":"Adair","year":"2001","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.canlet.2024.217405_bib25","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1159\/000334273","article-title":"N-Acetylcysteine reverses mitochondrial dysfunctions and behavioral abnormalities in 3-nitropropionic acid-induced Huntington's disease","volume":"9","author":"Sandhir","year":"2012","journal-title":"Neurodegener. Dis."},{"issue":"4","key":"10.1016\/j.canlet.2024.217405_bib26","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1097\/WNF.0b013e31829ae713","article-title":"N-Acetylcysteine boosts brain and blood glutathione in Gaucher and Parkinson diseases","volume":"36","author":"Holmay","year":"2013","journal-title":"Clin. Neuropharmacol."},{"issue":"3","key":"10.1016\/j.canlet.2024.217405_bib27","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1002\/npr2.12360","article-title":"Effects of N-acetylcysteine on oxidative stress biomarkers, depression, and anxiety symptoms in patients with multiple sclerosis","volume":"43","author":"Khalatbari","year":"2023","journal-title":"Neuropsychopharmacol Rep"},{"issue":"16","key":"10.1016\/j.canlet.2024.217405_bib28","doi-asserted-by":"crossref","first-page":"3478","DOI":"10.1200\/JCO.2002.07.061","article-title":"Neuroprotective effect of reduced glutathione on oxaliplatin-based chemotherapy in advanced colorectal cancer: a randomized, double-blind, placebo-controlled trial","volume":"20","author":"Cascinu","year":"2002","journal-title":"J. Clin. Oncol."},{"issue":"2","key":"10.1016\/j.canlet.2024.217405_bib29","doi-asserted-by":"crossref","first-page":"123","DOI":"10.2165\/00003088-199120020-00004","article-title":"Clinical pharmacokinetics of N-acetylcysteine","volume":"20","author":"Holdiness","year":"1991","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.canlet.2024.217405_bib30","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.redox.2015.07.012","article-title":"Effects of N-acetylcysteine, oral glutathione (GSH) and a novel sublingual form of GSH on oxidative stress markers: a comparative crossover study","volume":"6","author":"Schmitt","year":"2015","journal-title":"Redox Biol."},{"issue":"1","key":"10.1016\/j.canlet.2024.217405_bib31","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s10549-020-05762-8","article-title":"Evaluation of the effect of N-acetylcysteine on the prevention and amelioration of paclitaxel-induced peripheral neuropathy in breast cancer patients: a randomized controlled study","volume":"183","author":"Khalefa","year":"2020","journal-title":"Breast Cancer Res. Treat."},{"issue":"1","key":"10.1016\/j.canlet.2024.217405_bib32","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s12987-017-0075-0","article-title":"Dose escalation study of intravenous and intra-arterial N-acetylcysteine for the prevention of oto- and nephrotoxicity of cisplatin with a contrast-induced nephropathy model in patients with renal insufficiency","volume":"14","author":"D\u00f3sa","year":"2017","journal-title":"Fluids Barriers CNS"},{"issue":"13","key":"10.1016\/j.canlet.2024.217405_bib33","doi-asserted-by":"crossref","first-page":"2410","DOI":"10.1158\/1078-0432.CCR-23-0252","article-title":"Intravenous N-acetylcysteine to prevent cisplatin-induced hearing loss in children: a nonrandomized controlled phase I trial","volume":"29","author":"Orgel","year":"2023","journal-title":"Clin. Cancer Res."},{"issue":"10","key":"10.1016\/j.canlet.2024.217405_bib34","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines9101406","article-title":"Cisplatin mouse models: treatment, toxicity and translatability","volume":"9","author":"Per\u0161e","year":"2021","journal-title":"Biomedicines"},{"issue":"1","key":"10.1016\/j.canlet.2024.217405_bib35","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1056\/NEJMoa052985","article-title":"Intraperitoneal cisplatin and paclitaxel in ovarian cancer","volume":"354","author":"Armstrong","year":"2006","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.canlet.2024.217405_bib36","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0175654","article-title":"Isoflurane anesthesia promotes cognitive impairment by inducing expression of \u03b2-amyloid protein-related factors in the hippocampus of aged rats","volume":"12","author":"Zhang","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.canlet.2024.217405_bib37","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.neuroscience.2017.10.048","article-title":"Neurobiological mechanisms of chemotherapy-induced cognitive impairment in a transgenic model of breast cancer","volume":"369","author":"Winocur","year":"2018","journal-title":"Neuroscience"},{"issue":"3","key":"10.1016\/j.canlet.2024.217405_bib38","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1080\/13803390903032537","article-title":"Prechemotherapy alterations in brain function in women with breast cancer","volume":"32","author":"Cimprich","year":"2010","journal-title":"J. Clin. Exp. Neuropsychol."},{"issue":"34","key":"10.1016\/j.canlet.2024.217405_bib39","doi-asserted-by":"crossref","first-page":"4085","DOI":"10.1200\/JCO.2015.63.0905","article-title":"Cognitive function in patients with colorectal cancer who do and do not receive chemotherapy: a prospective, longitudinal, controlled study","volume":"33","author":"Vardy","year":"2015","journal-title":"J. Clin. Oncol. : official journal of the American Society of Clinical Oncology"}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383524008000?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383524008000?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T12:06:34Z","timestamp":1777550794000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304383524008000"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":39,"alternative-id":["S0304383524008000"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2024.217405","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"N-acetylcysteine prevents cisplatin-induced cognitive impairments in an ovarian cancer rat model","name":"articletitle","label":"Article Title"},{"value":"Cancer Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canlet.2024.217405","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"217405"}}